Positron Secures Multiple PET-CT Orders from Leading Cardiology Practices

Four 64-slice PET-CT scanners and long-term service deals go to three nuclear cardiology practices, highlighting cardiac PET adoption and Positron's role.

Published on Feb. 18, 2026

Got story updates? Submit your updates here. ›

Positron Corporation, a leader in molecular imaging technology and services, has announced the sale of four PET-CT 64-slice scanners, along with associated long-term services agreements, to three distinguished nuclear cardiology practices led by nationally recognized physicians. These new customer engagements underscore the adoption of Positron's next-generation PET-CT technology and comprehensive services solution.

Why it matters

As cardiac PET continues to replace legacy imaging modalities, providers are increasingly seeking solutions that deliver both superior clinical performance and sustainable, viable economics. This continued adoption reflects growing confidence in the modality and recognition of Positron's ability to support practices with advanced PET-CT technology, exceptional service, and a partnership-oriented approach.

The details

Positron's PET-CT scanners are engineered to optimize both clinical outcomes and operational efficiency, providing high-resolution anatomic and functional imaging for both cardiac and oncology applications. Key features include a 72cm wide-bore gantry for enhanced patient comfort, high-sensitivity detector technology that supports reduced radiation exposure, and a compact footprint, the smallest and lightest in its class, making it ideal for most clinical environments. Positron's advanced data acquisition capabilities deliver fast, high precision imaging, enhancing diagnostic confidence while expanding the scope of studies physicians can perform.

  • Positron Corporation announced the sale on February 17, 2026.

The players

Positron Corporation

A medical technology company that co-develops, manufactures, and sells state-of-the-art PET and PET-CT imaging systems and clinical services to nuclear medicine healthcare providers throughout North America.

Adel Abdullah

The President and Chairman of Positron Corporation.

Shenyang Intelligent Neuclear Technology Co.

A subsidiary of Neusoft Medical Systems, which is a co-developer, supplier, and R&D venture partner with Positron Corporation.

Got photos? Submit your photos here. ›

What they’re saying

“As cardiac PET continues to replace legacy imaging modalities, providers are increasingly seeking solutions that deliver both superior clinical performance and sustainable, viable economics.”

— Adel Abdullah, President and Chairman of Positron Corporation (stocktitan.net)

What’s next

Positron will continue to position itself as a trusted partner to nuclear cardiology practices seeking to transition to PET-CT imaging with confidence, efficiency, and long-term economic value.

The takeaway

Positron's continued success in securing PET-CT orders from leading cardiology practices highlights the growing adoption of cardiac PET imaging and the company's ability to provide advanced technology, exceptional service, and a partnership-oriented approach that meets the needs of healthcare providers.